Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Crespo Blas Coll currently holds 1,157 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Crespo Blas Coll has been a net seller of GPCR stock. They have purchased $0 and sold $144.9K worth of shares.
Crespo Blas Coll's most recent insider trade was on Sep 21, 2026, when they sold 4,008 shares at $36.15 per share.
Crespo Blas Coll serves as Executive at Structure Therapeutics Inc. (GPCR). They have executed 11 insider transactions totaling $144.9K over their tenure at the company.
Crespo Blas Coll holds the position of Executive at Structure Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Crespo Blas Coll has shown a selling trading pattern, with $0 in total purchases and $144.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Crespo Blas Coll was on Mar 3, 2026, when they sold $248.2K worth of GPCR shares. This transaction involved 11,826 shares at $20.99 per share.
Crespo Blas Coll currently owns 1,157 shares of Structure Therapeutics Inc. (GPCR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Crespo Blas Coll's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Crespo Blas Coll has 11 Form 4 filings on record as an insider at Structure Therapeutics Inc..
Set alerts for Crespo Blas Coll and 40,000+ other insiders.